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Abstract
Background: To validate the association between obesity and penile cancer at a population level, we conducted a
matched case–control study linking the Iowa Department of Motor Vehicles Drivers’ License Database (DLD) with
cancer surveillance data collected by the State Health Registry of Iowa (SHRI).
Methods: All men diagnosed with invasive penile squamous cell carcinoma from 1985 to 2010 were identified by
SHRI. Two hundred sixty-six cancer cases and 816 cancer-free male controls, selected from the Iowa DLD, were
matched within 5-year age and calendar year strata. Body mass index (BMI) was calculated using self-reported
height and weight from the DLD.
Results: Conditional logistic regression was used to evaluate the association between BMI and the risk of developing
invasive penile cancer. Obesity was significantly associated with an increased risk of developing penile cancer. For every
five-unit increase in BMI the risk of invasive penile cancer increased by 53 % (OR 1.53, 95 % CI 1.29-1.81, p < 0.0001).
Conclusion: We previously reported an association between obesity and higher risk of invasive penile cancer and
advanced cancer stage at diagnosis in a hospital-based retrospective study. This population-based study confirms an
association between obesity and invasive penile cancer.
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Background
Penile cancer accounts for 0.4–0.6 % of malignancies in
the United States and Western Europe [1]. Lack of neo-
natal circumcision, poor genital hygiene, phimosis, hu-
man papilloma virus (HPV) infection and smoking are
all risk factors for invasive penile cancer [2]. In a
hospital-based retrospective study, we reported an asso-
ciation between obesity and higher risk of having inva-
sive penile cancer after controlling for race and smoking
status [3]. In order to validate the association between
obesity and penile cancer at the population level, we
conducted a matched case–control study linking the
Iowa Department of Motor Vehicles Drivers’ License
Database (DLD) with the State Health Registry of Iowa
(SHRI), which is a member of the Surveillance, Epidemi-
ology, and End Results (SEER) Program [4].
Methods
Institutional Review Board approval was obtained for
this study. Cancer cases were ascertained by the SHRI as
part of its surveillance mandate. All male Iowa residents
diagnosed at 18+ years of age between 1985 and 2010
with microscopically-confirmed invasive penile squa-
mous cell carcinoma were identified. These criteria
yielded an initial cohort of 278 cases. The DLD was ob-
tained from the Iowa Department of Motor Vehicles.
This database contains full name, date of birth, license
issue date, and self-reported height and weight. Each
person in the database may have multiple records that
correspond to successive license renewals.
Data from the SHRI (for diagnoses made between
1985 and 2010) and the DLD (for licenses issued in
1985, 1993, 2008 and 2012) were linked using full name,
social security number and date of birth. Of the 278 ini-
tially identified penile cancer cases, 266 (96 %) were suc-
cessfully matched to one or more records in the DLD. A
control group of males were randomly selected from the
Iowa DLD, and SHRI records were checked to confirm
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that these men had not been diagnosed with cancer. These
controls were randomly selected from within 5-year calen-
dar year strata from 1985 to 2012 (according to time of
diagnosis for cases and time of DL issuance for controls)
and 5-year age strata for ages 30 through 90+. Matching
was done in a 3:1 ratio, yielding 798 controls.
Body mass index (BMI) was calculated using self-
reported height and weight from the DLD and catego-
rized as at or below normal weight (<25), overweight
(25–29.9), or obese (≥30) according to World Health
Organization (WHO) criteria [5]. Because DL issuance
dates (and corresponding BMIs) do not often coincide
closely with dates of diagnoses (Table 1), linear mixed ef-
fects regression was used to estimate BMI at the time of
diagnosis for each case. All available BMIs calculated
from the DLD information were included in the regres-
sion analysis and modeled as a function of (1) fixed ef-
fects for linear temporal trends prior to and after
diagnosis and (2) random effects for case-specific mean
differences. The regression-derived estimates of BMI at
diagnosis were then used in the subsequent analysis of
cancer risk. This was not necessary for controls since
their BMIs were calculated directly from DLs selected to
coincide with the diagnosis dates of their matched cases.
Conditional logistic regression was used to evaluate the
association between BMI and risk of developing invasive
penile cancer, while adjusting for the 5-year age and cal-
endar year matching strata which controlled for changes
in association over time. Estimated effects of BMI are re-
ported as odds ratios, along with 95 % confidence inter-
vals. All statistical tests were two-sided and assessed for
significance at the 0.05 level.
Results
The mean age of cases and controls were 68.3 and
69.3 years, respectively. In the mixed effects regression
analysis for penile cancer patients, BMIs increased at an
estimated rate of 1.0 unit every 10 years (95 % CI: 0.7 -
1.3; p < 0.0001). A non-significant decreased rate of 0.1
units (95 % CI: -0.4 - 0.5; p = 0.52) was estimated for the
change in BMI after diagnosis.
Penile cancer cases were significantly more likely to be
overweight or obese as compared to controls (Table 2).
Based on conditional logistic regression, as compared to
men with a normal weight (BMI <25), the risk of invasive
penile cancer increased with increasing obesity, with an
odds ratio of 2.64 (95 % CI 1.81-3.86; p = 0.0103) for over-
weight men and 3.24 (95 % CI 2.07-5.08; p = 0.0002) for
obese men. When BMI was treated as a continuous
variable, the risk of invasive penile cancer increased by an
estimated 53 % (OR 1.53, 95 % CI 1.29-1.81, p < 0.0001 for
every five-unit increase in BMI [Table 2]).
A sensitivity analysis was performed to assess the ef-
fect of using regression-derived estimates of BMI at
diagnosis. This was accomplished by repeating the risk
analysis using observed BMIs from the subset of cases
who had DL issue dates prior to and within 5 years of
diagnosis. Estimated odds ratios were higher in the sen-
sitivity analysis, albeit with wider confidence intervals;
thus suggesting that risk estimates are not artificially in-
flated by the use of case-estimated BMIs.
Discussion
In this population-based case–control study, we found in-
creasing BMI was associated with higher risk of develop-
ing invasive penile cancer. These results are consistent
with our previous hospital-based study, which showed the
odds of having invasive penile cancer doubled with each
five-unit increase in BMI [3]. To our knowledge, this is
the first population-based case–control study investigating
the role of BMI in penile cancer incidence. Strengths of
this study include the ability to capture a large number of
penile cancer cases given its rarity and utilizing two large
population-based databases (SHRI and the Iowa DLD)
which are not subject to referral bias.
The link between obesity and cancer is gaining accept-
ance and it was recently reported that 3.6 % of all new
cancers in 2012 were attributable to high BMI [6]. We
hypothesize the association as it relates to penile cancer
is secondary to obesity-related mechanisms such as im-
paired genital hygiene and self-examination, buried penis
with smegma accumulation and functional phimosis; all
risk factors for development of penile cancer. Obesity
may also lead to diabetes, which increases the risk of
phimosis and the risk of penile cancer [7]. Other, more
systemic obesity-associated carcinogenesis mechanisms,
such as chronic inflammation, oxidative stress and insu-
lin resistance may also play a role in the development of
penile cancer [8].
This study is limited by the inability to control for
other risk factors of penile cancer such as circumcision
status, smoking history and race. As circumcision is not
associated with obesity, and 93 % of Iowa residents are
Caucasian [9], these factors are unlikely to confound
these results. Also, smoking is inversely associated with
obesity [10], and any confounding due to smoking will
bias the study towards the null and unlikely to explain
our findings. Furthermore, in our previous case series
these factors were controlled for and an association was
Table 1 Summary of the number and timing of drivers’ licenses
available for penile cancer cases relative to diagnosis
DL Issued N Number of licenses Years to closest license
Mean (SD) Range Mean (SD) Range
Before diagnosis 262 1.5 (0.7) 1–4 8.8 (6.7) 0–25
After diagnosis 90 1.3 (0.6) 1–4 6.6 (5.6) 1–22
Before or after 266 1.9 (0.9) 1–5 6.6 (5.9) 0–25
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still found [3]. A second limitation is the use of self-
reported height and weight. This has been reported to
underestimate obesity prevalence’s in men [11]; however,
this underreporting should be consistent between cases
and controls and will bias the study towards the null,
minimizing the difference seen. Therefore, our results
could actually underestimate the effects of obesity on
penile cancer risk. Furthermore, the use of the Iowa
DLD as a population-based sampling frame has been
shown to include 97 % of men on the state’s tumor
registry, therefore not excluding the less affluent who
may be at highest risk of penile cancer [12]. Finally, tem-
poral differences in BMI and the time of diagnosis ne-
cessitated the use of case-estimated BMIs; however, a
sensitivity analysis indicated that this did not artificially
inflate risk estimates.
Conclusions
Many adverse health consequences result from obesity, in-
cluding increased risk for several cancers. This study
shows that obesity is associated with an increased risk of
developing invasive penile cancer. Penile cancer is a mor-
bid condition and therapeutic options for advanced cancer
are limited. Obesity may represent a modifiable risk factor
for the development of penile cancer. Greater emphasis
on education of obese men about this risk might encour-
age weight loss and persuade them to perform periodic
genital self-examination and seek care early.
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